Related Experiment Videos
Neuroblastoma
1Department of Pediatrics, University of Mainz Medical School, Germany.
World Journal of Urology
|January 1, 1995
Summary
Neuroblastoma is a childhood cancer from sympathetic neuroblasts, presenting varied clinical behaviors. Early diagnosis and advanced treatments like stem cell transplantation offer hope, though prognosis for metastatic disease remains challenging.
Area of Science:
- Pediatric Oncology
- Molecular Biology
- Urology
Background:
- Neuroblastoma originates from sympathetic neuroblasts, affecting infants and young children.
- Clinical manifestations range from spontaneous regression to aggressive, therapy-resistant malignant development.
- Abdominal neuroblastoma is a key differential diagnosis for urologists.
Purpose of the Study:
- To review the current understanding of neuroblastoma, including its diverse characteristics.
- To highlight recent advances in molecular biology suggesting distinct neuroblastoma subtypes.
- To discuss diagnostic methods, staging, and treatment challenges.
Main Methods:
- Review of existing literature on neuroblastoma diagnosis, molecular biology, and treatment.
- Analysis of diagnostic markers, including catecholamines and tumor histology.
- Examination of international consensus on diagnosis, staging, and treatment response.
Main Results:
- Neuroblastoma exhibits significant heterogeneity in location, growth, and biologic behavior.
- Molecular biology research supports the hypothesis of at least two distinct neuroblastoma types.
- Elevated catecholamines and tumor histology are crucial for diagnosis.
- Despite combined therapies, prognosis for older patients with metastatic disease remains poor.
Conclusions:
- International consensus on diagnosis and staging is vital for consistent patient management.
- Screening programs aim for early detection, but statistical benefit is unproven.
- Current treatment trials focus on autologous peripheral blood cell and bone marrow transplantation.